Syndax Pharmaceuticals Overview
Syndax Pharmaceuticals Target Price
Analysts' 12-month price predictions for SNDX.
Get informed when a big investor buys or sells
+ FollowShare Price
$21.82
Average Target Price
$38.50
76.4% upside
76.4% upside4 analysts in the last 4 months
High: $46 | Low: $31
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-12 | GuggenheimBrad Canino | $31 | 42.1% upside |  |
| 2026-06-03 | H.C. WainwrightAndres Maldonado | $40 | 83.3% upside | |
| 2026-05-04 | Stifel Nicolaus | $46 | 110.8% upside | |
| 2026-05-01 | Barclays | $37 | 69.6% upside | |
| 2026-02-27 | Stifel NicolausStephen Willey | $45 | 106.2% upside | |
| 2025-11-24 | Barclays | $35 | 60.4% upside | |
| 2025-11-04 | UBS | $38 | 74.2% upside | |
| 2025-11-04 | BarclaysPeter Lawson | $22 | 0.8% upside | |
| 2025-09-10 | Stifel Nicolaus | $44 | 101.6% upside | |
| 2025-07-15 | UBSDavid Dai | $35 | 60.4% upside | |
| 2025-07-10 | Goldman SachsCorinne Johnson | $18 |  17.5% downside | |
| 2024-11-13 | ScotiabankGeorge Farmer | $18 | 17.5% downside | |
| 2024-10-24 | UBSDavid Dai | $37 | 69.6% upside | |
| 2024-08-15 | CitigroupYigal Nochomovitz | $34 | 55.8% upside | |
| 2024-08-15 | Bank of America SecuritiesJason Zemansky | $31 | 42.1% upside | |
| 2024-08-15 | BarclaysPeter Lawson | $33 | 51.2% upside | |
| 2024-07-30 | Bank of America SecuritiesJason Zemansky | $30 | 37.5% upside | |
| 2024-06-28 | JefferiesKelly Shi | $37 | 69.6% upside | |
| 2024-05-09 | Stifel NicolausBradley Canino | $40 | 83.3% upside | |
| 2023-01-03 | J.P. Morgan | $41 | 87.9% upside | |
| 2022-12-12 | Goldman Sachs | $39 | 78.7% upside | |
| 2022-12-12 | H.C. Wainwright | $33 | 51.2% upside | |